Concordia

This page shows the latest Concordia news and features for those working in and with pharma, biotech and healthcare.

Concordia accused of overcharging NHS for thyroid drug

Markets Authority (CMA), which says Concordia “abused its dominant position to overcharge the NHS”. ... Concordia said it is “working to better understand the CMA's position and will continue to work constructively to resolve these matters”.

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest Intelligence

Pharma deals in September 2015

Transformational deals. The two largest deals announced this month were Cinven's sale of Amdipharm Mercury (AMCo) to Concordia Healthcare and Actelion's move to acquire ZS Pharma, at $3.5bn ... level. AMCo's commercial footprint reaches across 100
Medius Deal Watch table for March 2015

J&J divest subsidiary marketing vascular devices. 1, 944. Covis / Concordia.
Pharma deals in March 2015

Covis (asset). Concordia. 1.2. 8.2. NR. Hyperion. Horizon. 1.1. 9.6. 35%.
Deal Watch table for March 2014

341. Revive Pharmaceuticals/ Concordia Healthcare. Product acquisition. Donnatal, adjunctive therapy for IBS and acute enterocolitis (marketed).

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company

Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

Could formulary intelligence be your brand differentiator?: Proprietary research, and the COVID-19 experience, shows how formulary intelligence can drive competitive advantage at launch...
How COVID-19 is accelerating the threat of antimicrobial resistance: Why antimicrobial resistance needs to be addressed with the same urgency as COVID-19...
Improve clinical trials through patient journey mapping: Could patient journey mapping be your solution to improving clinical study recruitment and retention? While awareness of clinical studies is low across the population, it’s not the only issue. It’s...